Evogene Company Profile, Contacts & Intelligence
Evogene Overview
Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase probability of success while reducing development time and cost. Evogene established three unique technological engines – MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each technological engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). Evogene uses its technological engines to develop products through subsidiaries and with strategic partners. Currently, Evogene’s main subsidiaries utilize the technological engines to develop human microbiome-based therapeutics by Biomica Ltd., ag-chemicals by AgPlenus Ltd. and ag-biologicals by Lavie Bio Ltd. For more information, please visit: www.evogene.com
- Headquarters
- Rehovot, Al Awsat, Il
- Website
- evogene.com
- Industry
- Biotechnology Research
- Founded
- 2002
- Stock Symbol
- EVGN
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Evogene Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Evogene People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Evogene Workforce Composition
Seniority breakdown across 39 visible profiles.
Evogene Technology & Talent
Technology-related job titles represented in the visible people data.
Compare Similar Companies to Evogene
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Pluri | Biotechnology Research | 254 | View company |
| Protalix Biotherapeutics | Biotechnology Research | 192 | View company |
| Immunai | Biotechnology Research | 184 | View company |
| CytoReason | Biotechnology Research | 129 | View company |
| MeMed | Biotechnology Research | 107 | View company |
| Nucleai | Software Development | 79 | View company |
| Anima Biotech | Biotechnology Research | 67 | View company |
| BiomX (NYSE: PHGE) | Biotechnology Research | 64 | View company |
| NeuroKaire (formerly Genetika+) | Biotechnology Research | 45 | View company |
| Lavie Bio | Biotechnology Research | 41 | View company |